These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6335839)

  • 21. Detection of beta lactamase producing bacteria by Cefinase: comparison with three other methods.
    Qadri SM; Perryman F; Flournoy DJ; de Silva MI
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Nov; 255(4):489-93. PubMed ID: 6419492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Media supplemented with nalidixic acid for the isolation of gram negative anaerobic bacteria.
    Nadaud M
    Zentralbl Bakteriol Orig A; 1977 Nov; 239(3):375-8. PubMed ID: 203144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Directed isolation of gram-negative asporogenous bacteria from natural substrates].
    Ivanitskaia LP; Singal EM; Bodunkova LE; Ostanina LN; Baturina MV
    Antibiotiki; 1984 Oct; 29(10):725-9. PubMed ID: 6391365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of extended spectrum beta lactamases production with cephalosporin resistance in gram negative bacilli.
    Ghatole M; Manthalkar P; Kandle S; Yemul V; Jahagirdar V
    Indian J Pathol Microbiol; 2004 Jan; 47(1):82-4. PubMed ID: 15471144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Occurrence of extended spectrum beta-lactamases (ESBL) and inducible beta-lactamases (IBL) in clinical strains of gram-negative rods].
    Rokosz A; Sawicka-Grzelak A
    Med Dosw Mikrobiol; 1998; 50(1-2):31-9. PubMed ID: 9857611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
    Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial and antioxidant activities in Sideritis italica (Miller) Greuter et Burdet essential oils.
    Basile A; Senatore F; Gargano R; Sorbo S; Del Pezzo M; Lavitola A; Ritieni A; Bruno M; Spatuzzi D; Rigano D; Vuotto ML
    J Ethnopharmacol; 2006 Sep; 107(2):240-8. PubMed ID: 16690235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
    Hrabák J
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activity of Acalypha indica L.
    Govindarajan M; Jebanesan A; Reetha D; Amsath R; Pushpanathan T; Samidurai K
    Eur Rev Med Pharmacol Sci; 2008; 12(5):299-302. PubMed ID: 19024213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parenteral carbapenems.
    Shah PM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging epidemic of metallo-beta-lactamase-mediated resistances.
    Jones RN; Biedenbach DJ; Sader HS; Fritsche TR; Toleman MA; Walsh TR
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):77-84. PubMed ID: 15698711
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibilities. Middle Eastern Study Group.
    Shibl AM
    Chemotherapy; 1992; 38(5):324-9. PubMed ID: 1286574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase.
    Farmer TH; Reading C
    J Chemother; 1989 Jul; 1(4 Suppl):331-3. PubMed ID: 16312426
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates.
    Ravagnan G; Piccolomini R; Speciale AM; Russo G; Renzini G
    Chemotherapy; 1985; 31(3):191-9. PubMed ID: 3996087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin (BAY O 9867). Comparative in vitro activity study.
    Canton E; Garcia J; Vila B; Santos M; Gobernado M
    Microbiol Esp; 1984; 37(3-4):73-9. PubMed ID: 6242123
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of saccharin on growth and acid production of glucose-grown pathogenic and oral bacteria.
    Linke HA; Doyle GA
    Microbios; 1985; 42(169-170):163-73. PubMed ID: 4033457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between beta-lactamase production and the test of in vitro enzyme induction in 70 strains of gram-negative bacteria isolated in a hospital environment].
    Bovelacci A; Foà-Tomasi L; Ramacciotti PG
    Ann Sclavo; 1982; 24(6):586-95. PubMed ID: 6821296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.